Health ❯ Diabetes ❯ Type 2 Diabetes

Treatment Options

GLP-1 Receptor Agonists GLP-1 Agonists Clinical Trials GLP-1 Medications Ozempic Mounjaro vs Ozempic Mounjaro GLP-1 Therapy GLP-1 Drugs Oral Medications Orforglipron Medications Medication Semaglutide Elenolic Acid Tirzepatida Medication Management Weight Loss Medications Weight Loss Injections Injectable vs Oral Medications Medication Effects GLP-1 Therapies Semaglutide Injection Injectable Medications CagriSema Tirzepatide Weight Management Insulin Glargine Rybelsus Wegovy Novo Nordisk

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

The retrospective TriNetX findings spurred calls for randomized trials to test causation in interventional cardiology.

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials